The store will not work correctly when cookies are disabled.
Ethyl(2Z)-4,4,4-trifluoro-2-[2-(4-fluorophenyl)hydrazinylidene]-3-oxobutanoate
ID: ALA4858186
PubChem CID: 135475549
Max Phase: Preclinical
Molecular Formula: C12H10F4N2O3
Molecular Weight: 306.21
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CCOC(=O)/C(=N\Nc1ccc(F)cc1)C(=O)C(F)(F)F
Standard InChI: InChI=1S/C12H10F4N2O3/c1-2-21-11(20)9(10(19)12(14,15)16)18-17-8-5-3-7(13)4-6-8/h3-6,17H,2H2,1H3/b18-9-
Standard InChI Key: JNMIFBYVUUFRPR-NVMNQCDNSA-N
Molfile:
RDKit 2D
21 21 0 0 0 0 0 0 0 0999 V2000
41.0081 -1.7706 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4126 -2.4763 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4190 -1.0642 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
41.0018 -3.1827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4081 -3.8917 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.2298 -2.4789 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
42.6361 -3.1880 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
43.4533 -3.1906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1910 -1.7680 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7846 -1.0590 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.7801 -2.4744 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
39.3738 -1.7665 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
40.1846 -3.1801 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.7737 -3.8865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.1800 -4.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8561 -3.9026 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6725 -3.9056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.0842 -3.1986 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
44.6735 -2.4873 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
43.8584 -2.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
45.9014 -3.2001 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 3 2 0
2 4 1 0
4 5 2 0
2 6 2 0
6 7 1 0
7 8 1 0
1 9 1 0
9 10 1 0
9 11 1 0
9 12 1 0
4 13 1 0
13 14 1 0
14 15 1 0
8 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 8 1 0
18 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 306.21 | Molecular Weight (Monoisotopic): 306.0628 | AlogP: 2.29 | #Rotatable Bonds: 5 |
Polar Surface Area: 67.76 | Molecular Species: ACID | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 0.92 | CX Basic pKa: ┄ | CX LogP: 4.48 | CX LogD: 2.74 |
Aromatic Rings: 1 | Heavy Atoms: 21 | QED Weighted: 0.30 | Np Likeness Score: -1.28 |
References
1. Makhaeva GF, Lushchekina SV, Boltneva NP, Serebryakova OG, Kovaleva NV, Rudakova EV, Elkina NA, Shchegolkov EV, Burgart YV, Stupina TS, Terentiev AA, Radchenko EV, Palyulin VA, Saloutin VI, Bachurin SO, Richardson RJ.. (2021) Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold., 218 [PMID:33831780] [10.1016/j.ejmech.2021.113385] |